Septerna, Inc., a clinical-stage biotech company specializing in GPCR drug discovery, announced its management will participate in four investor conferences before the end of 2026. These include events hosted by Guggenheim, Stifel, UBS, and Evercore across Boston, New York, London, and Miami. The presentations will be available via live webcast on Septerna's website, providing investors insight into the company's innovative drug development pipeline. This visibility could enhance investor awareness and support for Septerna's ongoing clinical programs.
Septerna's participation in upcoming investor conferences is presented here with a snapshot of the health sector on Pluang as of Nov 03, 2026 20:11 WIB. Among 150 priced US health stocks, 75 rose and 69 fell. Notably, PHG (Koninklijke Philips NV) gained 5.11% to USD 29.00 with a typical hold time of 86 days, contrasting with TVTX (Travere Therapeutics Inc.) and INO (Inovio Pharmaceuticals Inc.), which declined by 6.15% and 6.08% to USD 46.23 and USD 1.77 respectively, with typical hold times of 19 and 42 days. Pluang order activity for INO showed a slight sell bias at 51% Sell / 49% Buy.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
